SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1401MGI PHARMA Announces Presentation On Irofulven's Antitumor Activity in Pancrsim1-11/7/2001
1400Message 16589078Jim Oravetz-11/2/2001
1399I like how the number of authors on each paper or poster increases with time. seminole-11/1/2001
1398MGI PHARMA Presents Further Data On Irofulven's Antitumor Activity At 2001 sim1-11/1/2001
1397>>MINNEAPOLIS, MN & MONTREAL, QC, Nov. 1 /CNW/ - MGI PHARMA, INC., (Natuck-11/1/2001
1396Epigenomics and MethylGene to Investigate DNA Methylation Pattern Changes in Cannigel bates-10/30/2001
1395>>MINNEAPOLIS & MONTREAL--(BUSINESS WIRE)--Oct. 18, 2001-- MGI PHARMA,tuck-10/18/2001
1394Quarterly results and a nice list of fall medical meetings; biz.yahoo.comseminole-10/17/2001
1393>>MINNEAPOLIS--(BUSINESS WIRE)--Oct. 11, 2001--MGI PHARMA, INC., (Nasdaq:Mtuck-10/11/2001
1392>>MINNEAPOLIS & LUGANO, Switzerland--(BUSINESS WIRE)--Oct. 3, 2001--MGtuck-10/3/2001
1391New NCI sponsored phase II breast cancer trial for Irofulven using the biweekly David Cathcart-9/25/2001
1390>>MINNEAPOLIS--(BUSINESS WIRE)--Sept. 25, 2001--MGI PHARMA, INC., (Nasdaq:tuck-9/25/2001
1389>>MINNEAPOLIS & MONTREAL--(BUSINESS WIRE)--Aug. 21, 2001--MGI PHARMA, tuck-8/21/2001
1388MGI Pharma 2Q Loss 81c A Share MGI Pharma Inc. - Minneapolis <pre> 2ndJim Oravetz-7/18/2001
1387Yeah, Baby!!!!seminole-6/28/2001
1386MGI PHARMA Receives Fast Track Designation From FDA for Irofulven corporate-ir.David Cathcart-6/28/2001
1385MGI Pharma: FDA Grants Fast Track For Irofulven Dow Jones Newswires MINNEAPOLISJim Oravetz-6/28/2001
1384MGI PHARMA Initiates Drug Combination Trial of Irofulven and Gemzar in Patients sim1-6/19/2001
1383Taglich Brothers Announces Investment Opinion on MGI Pharma Taglich Brothers Resim1-6/4/2001
1382presume that this is old news to everyone here, but...... Message 15814485scaram(o)uche-5/17/2001
13814x per week schedule: Data were presented from a National Cancer Institute-sponsseminole-5/14/2001
1380MGI Pharma Agrees To Sell 4M Of Its Shrs Dow Jones Newswires MINNEAPOLIS -- In Jim Oravetz-5/9/2001
1379Another building block... MGI PHARMA Announces Issuance of Key Patent for InhibDavid Cathcart-4/25/2001
1378MGI PHARMA, INC. Statements of Operations David Cathcart-4/18/2001
1377MGI PHARMA Reports 2001 First Quarter Results MINNEAPOLIS, April 18 /PRNewswirDavid Cathcart-4/18/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News